Osilodrostat

Chemical formula: C₁₃H₁₀FN₃  Molecular mass: 227.242 g/mol  PubChem compound: 44139752

Therapeutic indications

Osilodrostat is indicated for:

Endogenous Cushing's syndrome

Population group: only adults (18 years old or older)

Hypercortisolism

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Osilodrostat is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: ISTURISA Film-coated tablet
Summary of Product Characteristics (SPC) 2023: ISTURISA Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈